Temsirolimus and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia

Clinical trial NCT00101088 · TERMINATED

Trial details

NCT number: NCT00101088
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Accelerated Phase Chronic Myelogenous Leukemia Blastic Phase Chronic Myelogenous Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Chronic Phase Chronic Myelogenous Leukemia Relapsing Chronic Myelogenous Leukemia

Start date: 2005-04-01
Primary completion: 2010-06-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.